Recent changes
Track the most recent changes to the wiki on this page.
9 December 2018
| m 13:48 | Cholangiocarcinoma (diff | hist) . . (+80) . . Jwarner (talk | contribs) (→Fluorouracil & Folinic acid {{#subobject:7bfb92|Regimen=1}}) |
| m 13:47 | Gemcitabine & Oxaliplatin for biliary tract cancer (diff | hist) . . (+1,272) . . Jwarner (talk | contribs) |
| m 13:13 | Chronic lymphocytic leukemia (CLL/SLL) - historical (diff | hist) . . (+8,922) . . Jwarner (talk | contribs) |
| m 12:04 | Chronic lymphocytic leukemia (CLL/SLL) (2 changes | history) . . (-4,549) . . [Jwarner (2×)] | |
| m | 12:04 (cur | prev) . . (+34) . . Jwarner (talk | contribs) (→FCR {{#subobject:b079e8|Regimen=1}}) | |
| m | 11:46 (cur | prev) . . (-4,583) . . Jwarner (talk | contribs) |
| m 10:57 | Adult T-cell leukemia-lymphoma (diff | hist) . . (+1,061) . . Jwarner (talk | contribs) (→CHOP-14 {{#subobject:3e53d9|Regimen=1}}) |
| m 10:49 | Adenocarcinoma of unknown primary (diff | hist) . . (+134) . . Jwarner (talk | contribs) (→Cisplatin monotherapy {{#subobject:21015c|Regimen=1}}) |
| m 10:46 | Non-small cell lung cancer (diff | hist) . . (+4,277) . . Jwarner (talk | contribs) |
8 December 2018
| m 22:10 | Waldenström macroglobulinemia (diff | hist) . . (+1) . . Jwarner (talk | contribs) (→Supportive medications) |
| m 20:46 | Vascular sarcoma (diff | hist) . . (+1,360) . . Jwarner (talk | contribs) (→ABV {{#subobject:4531b5|Regimen=1}}) |
| m 20:32 | Pancreatic cancer (diff | hist) . . (+2,449) . . Jwarner (talk | contribs) |
| m 20:09 | Conflict of interest (diff | hist) . . (+228) . . Jwarner (talk | contribs) |
| m 20:04 | Ovarian cancer (diff | hist) . . (+3,960) . . Jwarner (talk | contribs) (→Paclitaxel monotherapy {{#subobject:57d35e|Regimen=1}}) |
| m 19:02 | Nasopharyngeal carcinoma (diff | hist) . . (+1,030) . . Jwarner (talk | contribs) (→Cisplatin & Fluorouracil {{#subobject:b42ea5|Regimen=1}}) |
| m 18:32 | NK/T-cell lymphoma (diff | hist) . . (0) . . Jwarner (talk | contribs) (→Regimen {{#subobject:9874b6|Variant=1}}) |
| m 18:27 | T-cell acute lymphoblastic leukemia (diff | hist) . . (-4) . . Jwarner (talk | contribs) (→Methotrexate, Pegaspargase, Vincristine {{#subobject:dd9475|Regimen=1}}) |
| m 18:08 | Myelodysplastic syndrome (diff | hist) . . (+1,063) . . Jwarner (talk | contribs) |
| m 14:58 | Atezolizumab (Tecentriq) (diff | hist) . . (+522) . . Jwarner (talk | contribs) |
| m 14:52 | Non-small cell lung cancer (2 changes | history) . . (+877) . . [Jwarner (2×)] | |
| m | 14:52 (cur | prev) . . (+193) . . Jwarner (talk | contribs) (→Atezolizumab & Bevacizumab {{#subobject:ef3aef|Regimen=1}}) | |
| m | 14:51 (cur | prev) . . (+684) . . Jwarner (talk | contribs) (→ABCP {{#subobject:ee72af|Regimen=1}}) |
| m 12:35 | Multiple myeloma - historical (diff | hist) . . (+3,774) . . Jwarner (talk | contribs) |
| m 11:55 | B-cell acute lymphoblastic leukemia, Ph-positive (diff | hist) . . (+28) . . Jwarner (talk | contribs) |
| m 11:42 | Multiple myeloma, relapsed/refractory (diff | hist) . . (+682) . . Jwarner (talk | contribs) |
| m 10:21 | Multiple myeloma, consolidation and maintenance (diff | hist) . . (+258) . . Jwarner (talk | contribs) |
| m 10:13 | Multiple myeloma, induction (2 changes | history) . . (+2,829) . . [Jwarner (2×)] | |
| m | 10:13 (cur | prev) . . (+258) . . Jwarner (talk | contribs) | |
| m | 09:36 (cur | prev) . . (+2,571) . . Jwarner (talk | contribs) (→RVD {{#subobject:97fba9|Regimen=1}}) |
7 December 2018
| m 22:53 | Hepatocellular carcinoma (diff | hist) . . (+1,349) . . Jwarner (talk | contribs) |
| m 22:31 | Colon cancer (2 changes | history) . . (+143) . . [Jwarner (2×)] | |
| m | 22:31 (cur | prev) . . (+134) . . Jwarner (talk | contribs) | |
| m | 21:24 (cur | prev) . . (+9) . . Jwarner (talk | contribs) (→Observation) |
| m 21:31 | Lomustine (Ceenu) (2 changes | history) . . (-64) . . [Jwarner (2×)] | |
| m | 21:31 (cur | prev) . . (-8) . . Jwarner (talk | contribs) (→Also known as) | |
| m | 21:27 (cur | prev) . . (-56) . . Jwarner (talk | contribs) |
| N 21:31 | Semustine (MeCCNU) (diff | hist) . . (+590) . . Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: Nitrosourea, alkylates DNA and RNA and may inhibit certain key enzymatic reactions by carbamoylation of amino acids in proteins. Very...") |
| m 21:26 | Colon cancer - historical (diff | hist) . . (+1,778) . . Jwarner (talk | contribs) (→MOF {{#subobject:42388e|Regimen=1}}) |
| m 21:15 | Mesothelioma (diff | hist) . . (+1,910) . . Jwarner (talk | contribs) |
| m 20:01 | Melanoma (diff | hist) . . (+8,090) . . Jwarner (talk | contribs) |
| m 17:15 | CNS melanoma (diff | hist) . . (+57) . . Jwarner (talk | contribs) (→Regimen {{#subobject:6cf5ae|Variant=1}}) |
| m 17:09 | Allogeneic HSCT (diff | hist) . . (+3) . . Jwarner (talk | contribs) (→GVHD prophylaxis) |
| m 17:08 | Acute myeloid leukemia (3 changes | history) . . (+589) . . [Jwarner (3×)] | |
| m | 17:08 (cur | prev) . . (+2,464) . . Jwarner (talk | contribs) (→Low-dose TBI, then allo HSCT {{#subobject:529ee7|Regimen=1}}) | |
| m | 17:08 (cur | prev) . . (-2,464) . . Jwarner (talk | contribs) (→IC & Norethandrolone {{#subobject:2034a1|Regimen=1}}) | |
| m | 17:05 (cur | prev) . . (+589) . . Jwarner (talk | contribs) |
| m 14:40 | Gastric cancer - historical (diff | hist) . . (+790) . . Jwarner (talk | contribs) |
| m 14:34 | Gastric cancer (diff | hist) . . (+2,712) . . Jwarner (talk | contribs) |
| m 13:54 | Cutaneous T-cell lymphoma (3 changes | history) . . (+391) . . [Jwarner (3×)] | |
| m | 13:54 (cur | prev) . . (+124) . . Jwarner (talk | contribs) (→Vorinostat monotherapy {{#subobject:6a3a5b|Regimen=1}}) | |
| m | 13:52 (cur | prev) . . (+133) . . Jwarner (talk | contribs) (→Methotrexate monotherapy {{#subobject:0ff378|Regimen=1}}) | |
| m | 13:44 (cur | prev) . . (+134) . . Jwarner (talk | contribs) (→PUVA) |
| m 13:01 | Endometrial cancer (4 changes | history) . . (+2,014) . . [Jwarner (4×)] | |
| m | 13:01 (cur | prev) . . (+714) . . Jwarner (talk | contribs) (→Endocrine therapy for advanced, recurrent, or metastatic disease) | |
| m | 12:13 (cur | prev) . . (+706) . . Jwarner (talk | contribs) (→Medroxyprogesterone acetate monotherapy {{#subobject:6c7bb9|Regimen=1}}) | |
| m | 10:03 (cur | prev) . . (+594) . . Jwarner (talk | contribs) (→Doxorubicin monotherapy {{#subobject:e5b103|Regimen=1}}) | |
| m | 09:55 (cur | prev) . . (0) . . Jwarner (talk | contribs) (→Whole abdominal radiation (WAI) {{#subobject:37c051|Regimen=1}}) |
| m 12:11 | Medroxyprogesterone acetate (MPA) (diff | hist) . . (+169) . . Jwarner (talk | contribs) |
